US Stock MarketDetailed Quotes
DSNKY Daiichi Sankyo (ADR)
- 32.130
- -0.440-1.35%
15min DelayClose Nov 1 16:00 ET
60.92BMarket Cap37.32P/E (TTM)
32.300High32.100Low55.63KVolume32.100Open32.570Pre Close1.79MTurnover0.00%Turnover Ratio46.70P/E (Static)1.90BShares42.48052wk High5.53P/B60.92BFloat Cap25.26052wk Low0.20Dividend TTM1.90BShs Float42.480Historical High0.62%Div YieldTTM0.61%Amplitude18.050Historical Low32.189Avg Price1Lot Size
About Daiichi Sankyo (ADR) Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Executive Chairman of the Board and Chief Executive Officer
- --
- Hiroyuki Okuzawa
- Director, President and Chief Operating Officer
- --
- Takashi Matsumoto
- Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Kazuaki Kama
- Chairman of the Board
- --
- Sawako Nohara
- Independent Director
- --
- Yo Honma
- Independent Director
- --
- Takaaki Nishii
- Independent Director
- --
- Yasuhiro Komatsu
- Independent Director
- --
Analysis
Price Target
No Data
Business Data
Revenue by product
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
